CBP-93872

CAS No. 67427-51-4

CBP-93872( CBP93872 | CBP 93872 )

Catalog No. M15571 CAS No. 67427-51-4

A potent G2 checkpoint inhibitor that specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CBP-93872
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent G2 checkpoint inhibitor that specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint.
  • Description
    A potent G2 checkpoint inhibitor that specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint; directly suppresses the growth of p53-mutated cancer cell lines with wild-type CDKN2A by eliciting G(1) arrest, but not CDKN2A-deleted and/or wild-type p53 lines; decreases phospho-cdc2 Y15 by inhibiting phosphorylation of Chk1; specifically inhibits DSB-mediated and Nbs1-dependent activation of ATR.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CBP93872 | CBP 93872
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ATM/ATR
  • Recptor
    ATM/ATR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    67427-51-4
  • Formula Weight
    259.14
  • Molecular Formula
    C10H15BrN2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(CNC1=CC=C(C)C=C1Br)CN
  • Chemical Name
    1-amino-3-((2-bromo-4-methylphenyl)amino)propan-2-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Harada N, et al. Anticancer Drugs. 2011 Nov;22(10):986-94. 2. Hirokawa T, et al. Cancer Res. 2014 Jul 15;74(14):3880-9. 3. Iwata T, et al. PLoS One. 2017 May 30;12(5):e0178221.
molnova catalog
related products
  • GSK 635416A

    GSK 635416A is a novel ATM inhibitor with highly selective radiosensitizing activity, inhibits radiation induced phosphorylation of ATM.

  • Chloroquine diphosph...

    Chloroquine diphosphate is used as an antimalarial drug and also functions to increase sensitivity of tumor cells to radiation and chemotherapy via inducing autophagy .

  • Camonsertib

    Camonsertib (RP-3500) is a novel, potent and selective ATR kinase inhibitor (ATRi) that exhibits potent antitumor effects with an IC50: 1.00 nM in biochemical assays.